Related Experiment Videos
Splenopancreatic field abnormality is not unique to trisomy 13
Luiz Cesar Peres1, Gustavo Henrique T de Sales Barbosa, Renata Scarpat Careta
1Department of Pathology, Ribeirão Preto Medical School, University of São Paulo, Av. Bandeirantes, 3900, Ribeirão Preto, SP 14049-900, Brazil. lcperes@fmrp.usp.br
Summary
Splenopancreatic fusion, a rare condition, is often linked to trisomy 13. However, this study found it in diverse congenital anomalies, suggesting it
Area of Science:
- Medical Genetics
- Developmental Biology
- Anatomical Pathology
Background:
- Splenopancreatic fusion is an uncommon congenital anomaly.
- It is typically associated with trisomy 13, presenting as a splenopancreatic field abnormality.
- Manifestations include ectopic splenic tissue in the pancreas, ectopic pancreatic tissue in the spleen, or fusion at the pancreatic tail and splenic hilum.
Observation:
- This study reports four unrelated cases of congenital anomalies.
- These cases included trisomy 21, osteocraniostenosis syndrome, isolated congenital heart defect, and prune belly syndrome with oligohydramnios sequence.
- Splenopancreatic fusion was observed in all four cases.
Findings:
- Splenopancreatic fusion can occur in conditions other than trisomy 13.
- The presence of splenopancreatic fusion was noted in diverse genetic and developmental disorders.
- This challenges the notion that splenopancreatic fusion is pathognomonic to trisomy 13.
Implications:
- The findings broaden the understanding of splenopancreatic fusion's occurrence in congenital anomalies.
- It suggests a potential, yet uncharacterized, shared developmental pathway or susceptibility.
- Further research is warranted to explore the etiological links and diagnostic significance of splenopancreatic fusion in various syndromes.